These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 32390392)
21. Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years. Yap DYH; Tang C; Ma MKM; Mok MMY; Chan GCW; Kwan LPY; Chan TM J Rheumatol; 2017 Sep; 44(9):1375-1383. PubMed ID: 28668803 [TBL] [Abstract][Full Text] [Related]
22. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV. Hanaoka H; Yamada H; Kiyokawa T; Iida H; Suzuki T; Yamasaki Y; Ooka S; Nagafuchi H; Okazaki T; Ichikawa D; Shirai S; Shibagaki Y; Koike J; Ozaki S Arthritis Res Ther; 2017 Jan; 19(1):4. PubMed ID: 28086993 [TBL] [Abstract][Full Text] [Related]
23. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis. Choi CB; Won S; Bae SC Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up. Pesickova SS; Rysava R; Lenicek M; Vitek L; Potlukova E; Hruskova Z; Jancova E; Honsova E; Zavada J; Trendelenburg M; Tesar V Arthritis Res Ther; 2015 Dec; 17():371. PubMed ID: 26704903 [TBL] [Abstract][Full Text] [Related]
25. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis. Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566 [TBL] [Abstract][Full Text] [Related]
26. Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis. Won J; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S Lupus; 2019 Oct; 28(11):1294-1301. PubMed ID: 31583978 [TBL] [Abstract][Full Text] [Related]
27. Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease. Yonemoto S; Hamano T; Fujii N; Shimada K; Yamaguchi S; Matsumoto A; Kubota K; Hashimoto N; Oka T; Senda M; Sakaguchi Y; Matsui I; Isaka Y PLoS One; 2018; 13(6):e0198825. PubMed ID: 29889895 [TBL] [Abstract][Full Text] [Related]
28. Predictive value of remission status after 6 months induction therapy in patients with proliferative lupus nephritis: a retrospective analysis. So MW; Koo BS; Kim YG; Lee CK; Yoo B Clin Rheumatol; 2011 Nov; 30(11):1399-405. PubMed ID: 21594768 [TBL] [Abstract][Full Text] [Related]
29. Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis. Yap DY; Yung S; Zhang Q; Tang C; Chan TM Lupus; 2016 Jan; 25(1):46-53. PubMed ID: 26251400 [TBL] [Abstract][Full Text] [Related]
30. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis. Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776 [TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response. Jónsdóttir T; Zickert A; Sundelin B; Henriksson EW; van Vollenhoven RF; Gunnarsson I Rheumatology (Oxford); 2013 May; 52(5):847-55. PubMed ID: 23287364 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka. Herath N; Ratnatunga N; Weerakoon K; Wazil A; Nanayakkara N BMC Res Notes; 2017 Feb; 10(1):80. PubMed ID: 28148285 [TBL] [Abstract][Full Text] [Related]
33. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort. Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri S; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A Lupus; 2019 Mar; 28(3):295-303. PubMed ID: 30700214 [TBL] [Abstract][Full Text] [Related]
34. Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis. Moon SJ; Park HS; Kwok SK; Ju JH; Kim HY; Park SH Clin Exp Rheumatol; 2013; 31(1):31-9. PubMed ID: 22935632 [TBL] [Abstract][Full Text] [Related]
35. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study. Mehra S; Usdadiya JB; Jain VK; Misra DP; Negi VS Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636 [TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy. Li C; Yap DYH; Chan G; Wen YB; Li H; Tang C; Li XM; Li XW; Chan TM J Rheumatol; 2019 Nov; 46(11):1478-1484. PubMed ID: 30877215 [TBL] [Abstract][Full Text] [Related]
37. Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation. Aung N; Dworakowski R; Byrne J; Alcock E; Deshpande R; Rajagopal K; Brickham B; Monaghan MJ; Okonko DO; Wendler O; Maccarthy PA Heart; 2013 Sep; 99(17):1261-6. PubMed ID: 23735935 [TBL] [Abstract][Full Text] [Related]
38. Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis. Medina-Rosas J; Fung WA; Su J; Touma Z Semin Arthritis Rheum; 2018 Feb; 47(4):557-564. PubMed ID: 28888363 [TBL] [Abstract][Full Text] [Related]
40. Development and validation of a prognostic nomogram for the renal relapse of lupus nephritis. Liu N; Li D; Zhou Y; Zhang X; Liu S; Ma R Med Clin (Barc); 2023 Oct; 161(7):277-285. PubMed ID: 37414598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]